Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-63,870
Closed -$6.72M 56
2025
Q4
$6.72M Buy
63,870
+3,704
+6% +$348K 2.56% 11
2025
Q3
$5.05M Buy
+60,166
New +$4.96M 1.98% 14
2024
Q4
Sell
-5,861
Closed -$666K 76
2024
Q3
$666K Sell
5,861
-3,737
-39% -$444K 0.32% 43
2024
Q2
$1.19M Buy
9,598
+6,584
+218% +$848K 0.6% 38
2024
Q1
$398K Sell
3,014
-57
-2% -$7.03K 0.22% 63
2023
Q4
$335K Sell
3,071
-406
-12% -$42.1K 0.2% 59
2023
Q3
$358K Sell
3,477
-40,472
-92% -$4.36M 0.19% 58
2023
Q2
$5.07M Buy
43,949
+12,906
+42% +$1.47M 3.29% 6
2023
Q1
$3.3M Buy
+31,043
New +$3.35M 2.25% 18

Other funds holding MRK

Fluent Financial's MRK Position: Q1 2026 in Review

Fluent Financial sold out of Merck (MRK) in Q1 2026, closing a stake of 63,870 shares — an estimated $6.72M sold.

Fluent Financial first reported a position in MRK in Q1 2023 and held it in 9 quarters. The position peaked at $6.72M in Q4 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fluent Financial reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Fluent Financial sold 63,870 Merck shares in Q1 2026, an estimated $6.72M.
  • Fluent Financial first reported a position in Merck in Q1 2023 and held it in 9 quarters.
  • Fluent Financial's Merck position peaked at $6.72M in Q4 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fluent Financial's 13F filing for Q1 2026, filed 15 Apr 2026.